These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 8281664)
41. [PAI-1, the primary plasmatic inhibitor of fibrinolysis. Physiopathologic role and molecular mechanisms]. Banfi C; Mussoni L; Tremoli E Minerva Endocrinol; 2002 Sep; 27(3):181-91. PubMed ID: 12091793 [TBL] [Abstract][Full Text] [Related]
42. Hormonal control of plasminogen activator inhibitor-1 gene expression and production in human adipose tissue: stimulation by glucocorticoids and inhibition by catecholamines. Halleux CM; Declerck PJ; Tran SL; Detry R; Brichard SM J Clin Endocrinol Metab; 1999 Nov; 84(11):4097-105. PubMed ID: 10566656 [TBL] [Abstract][Full Text] [Related]
43. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis. Vaughan DE; Lazos SA; Tong K J Clin Invest; 1995 Mar; 95(3):995-1001. PubMed ID: 7884001 [TBL] [Abstract][Full Text] [Related]
44. Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes. Crandall DL; Quinet EM; Morgan GA; Busler DE; McHendry-Rinde B; Kral JG J Clin Endocrinol Metab; 1999 Sep; 84(9):3222-7. PubMed ID: 10487691 [TBL] [Abstract][Full Text] [Related]
45. Insulin continues to induce plasminogen activator inhibitor 1 gene expression in insulin-resistant mice and adipocytes. Samad F; Pandey M; Bell PA; Loskutoff DJ Mol Med; 2000 Aug; 6(8):680-92. PubMed ID: 11055587 [TBL] [Abstract][Full Text] [Related]
46. Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1. Kimura H; Gejyo F; Suzuki Y; Suzuki S; Miyazaki R; Arakawa M Kidney Int; 1998 Nov; 54(5):1659-69. PubMed ID: 9844142 [TBL] [Abstract][Full Text] [Related]
47. PPARγ activation induces acute PAI-1 gene expression in the liver but not in adipose tissues of diabetic model mice. Oishi K; Tomita T; Itoh N; Ohkura N Thromb Res; 2011 Nov; 128(5):e81-5. PubMed ID: 21757225 [TBL] [Abstract][Full Text] [Related]
48. Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes. Trost S; Pratley R; Sobel B Curr Diab Rep; 2006 Feb; 6(1):47-54. PubMed ID: 16522281 [TBL] [Abstract][Full Text] [Related]
49. [A multicomparmental and multifactorial model of production of plasminogen activator inhibitor (PAI-1). I. Experimental studies]. Galajda P; Kubisz P; Mokán M Vnitr Lek; 1998 Dec; 44(12):718-21. PubMed ID: 10422516 [TBL] [Abstract][Full Text] [Related]
50. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Pandolfi A; Cetrullo D; Polishuck R; Alberta MM; Calafiore A; Pellegrini G; Vitacolonna E; Capani F; Consoli A Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1378-82. PubMed ID: 11498469 [TBL] [Abstract][Full Text] [Related]
51. Modulation of expression of monocyte/macrophage plasminogen activator activity and its implications for attenuation of vasculopathy. Lundgren CH; Sawa H; Sobel BE; Fujii S Circulation; 1994 Oct; 90(4):1927-34. PubMed ID: 7923681 [TBL] [Abstract][Full Text] [Related]
52. Elaboration of type-1 plasminogen activator inhibitor from adipocytes. A potential pathogenetic link between obesity and cardiovascular disease. Lundgren CH; Brown SL; Nordt TK; Sobel BE; Fujii S Circulation; 1996 Jan; 93(1):106-10. PubMed ID: 8616916 [TBL] [Abstract][Full Text] [Related]
54. Induction of plasminogen activator inhibitor type 1 and type 1 collagen expression in rat cardiac microvascular endothelial cells by interleukin-1 and its dependence on oxygen-centered free radicals. Okada H; Woodcock-Mitchell J; Mitchell J; Sakamoto T; Marutsuka K; Sobel BE; Fujii S Circulation; 1998 Jun; 97(21):2175-82. PubMed ID: 9626179 [TBL] [Abstract][Full Text] [Related]
55. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells. Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384 [TBL] [Abstract][Full Text] [Related]
56. [Plasminogen activator inhibitor (PAI-1) and diabetes mellitus. II. PAI-1 in insulin resistant conditions]. Galajda P; Sutarík L; Vladár L; Stasko J; Kubisz P; Mokán M Vnitr Lek; 1998 Feb; 44(2):111-4. PubMed ID: 9820087 [TBL] [Abstract][Full Text] [Related]
60. Potentiation by hypercholesterolemia of the induction of aortic intramural synthesis of plasminogen activator inhibitor type 1 by endothelial injury. Sawa H; Sobel BE; Fujii S Circ Res; 1993 Oct; 73(4):671-80. PubMed ID: 7690310 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]